<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00948363</url>
  </required_header>
  <id_info>
    <org_study_id>1335</org_study_id>
    <nct_id>NCT00948363</nct_id>
  </id_info>
  <brief_title>The Effect of Kiwi on Blood Pressure, Endothelial Function, Antioxidant Capacity and Gene Expression</brief_title>
  <official_title>The Effect of Kiwi on Blood Pressure, Endothelial Function, Antioxidant Capacity and Gene Expression in Mildly Hypertensive Subjects</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Oslo University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of Oslo</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Oslo University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine whether the intake of kiwi fruits will reduce
      systolic and diastolic blood pressure compared to intake of apples. The investigators
      hypothesize that the increased intake lutein or other components in the kiwi fruit will
      enhance nitric oxide bioavailability and lead to vascular relaxation.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      An interesting finding in the Oslo Antioxidant Study was that intake of 3 kiwi fruits reduced
      blood pressure in a clinical significant manner compared to controls. The mechanism for the
      blood pressure reducing effect of kiwi or the responsible components are not elucidated.
      However, plasma lutein levels and antioxidant capacity measured by the ferric reducing
      antioxidant power was increased in the kiwi group. Moreover, gene expression was also altered
      by the increased intake of kiwi.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>August 2009</start_date>
  <completion_date type="Actual">December 2010</completion_date>
  <primary_completion_date type="Actual">December 2010</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Blood pressure</measure>
    <time_frame>8 weeks</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Endothelial function</measure>
    <time_frame>8 weeks</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">118</enrollment>
  <condition>Hypertension</condition>
  <arm_group>
    <arm_group_label>Kiwi fruits</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Apple</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Kiwi fruits</intervention_name>
    <description>Daily intake of 3 kiwi fruits for 8 weeks</description>
    <arm_group_label>Kiwi fruits</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Apple</intervention_name>
    <description>Daily intake of 1 apple (equivalent in energy) for 8 weeks</description>
    <arm_group_label>Apple</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Systolic blood pressure 130-159 mmHg

          -  Diastolic blood pressure 85-99 mmHg

          -  Body mass index &lt;35 kg/m2

        Exclusion Criteria:

          -  Systolic blood pressure &gt;160 mmHg or &lt;129 mmHg

          -  Diastolic blood pressure &gt;100 mmHg or &lt;84 mmHg

          -  Current use or need for blood pressure lowering medication

          -  Symptomatic cardiovascular disease, diabetes, renal dysfunction, psychiatric disorder,
             pregnancy or lactation, history of obesity surgery.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>35 Years</minimum_age>
    <maximum_age>69 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Serena Tonstad, Professor</last_name>
    <role>Principal Investigator</role>
    <affiliation>Preventive Cardiology, Oslo University Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Department of Preventive Cardiology</name>
      <address>
        <city>Oslo</city>
        <zip>0407</zip>
        <country>Norway</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Oslo University Hospital</name>
      <address>
        <city>Oslo</city>
        <zip>0407</zip>
        <country>Norway</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Norway</country>
  </location_countries>
  <verification_date>June 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 27, 2009</study_first_submitted>
  <study_first_submitted_qc>July 28, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 29, 2009</study_first_posted>
  <last_update_submitted>June 28, 2017</last_update_submitted>
  <last_update_submitted_qc>June 28, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">June 29, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Oslo University Hospital</investigator_affiliation>
    <investigator_full_name>Tor Ole Klemsdal</investigator_full_name>
    <investigator_title>Chief Consultant</investigator_title>
  </responsible_party>
  <keyword>Kiwi fruits</keyword>
  <keyword>Blood pressure</keyword>
  <keyword>Endothelial function</keyword>
  <keyword>Antioxidant capacity</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Antioxidants</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

